NEWSROOM

XTI Aerospace to Present at the ThinkEquity Conference

XTI Aerospace to Present at the ThinkEquity Conference

ENGLEWOOD, Colo., October 24, 2024 - PRISM MediaWire - XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company") today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York.  Past ThinkEquity conferences have featured over 70 company presentations, 700+ attendees, and 500+ one-on-one meetings, providing a valuable platform for companies and investors to connect. Scott Pomeroy, Chief Executive Officer of...

read more
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

EDEN PRAIRIE, Minn., October 24, 2024 - PRISM MediaWire - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...

read more
Sidus Space to Present at the 2024 ThinkEquity Conference

Sidus Space to Present at the 2024 ThinkEquity Conference

CAPE CANAVERAL, FL, October 24, 2024 - PRISM MediaWire - Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), an innovative, agile space mission enabler, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Carol Craig, CEO, will...

read more
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Princeton, NJ, October 24, 2024 - PRISM MediaWire - Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

read more
BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens

BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens

BranchOut Peru Facility Now Operational, Driving Profitability Through High-Margin Production Key Highlights: Projecting $3.8M in Q1 revenue, with strong growth throughout the year Inflecting to Positive Cash Flow Beginning in Q1 2025 Peru Facility Now Operational, Producing Initial Orders and Capturing High Margins Nation’s Largest Warehouse Club Reorders $1.7M After Strong Per-Store Sales, Expanding Regions and Tripling SKUs. Planning 2025 Sales Strategy for the Ingredient Channel; in talks...

read more
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Glen Allen, VA, October 23, 2024 - PRISM MediaWire - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York.  The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

read more
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

MIAMI, FL., October 23, 2024 – PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, (“NRx,” the “Company”) and HOPE Therapeutics, Inc., a medical and technology driven company and wholly-owned subsidiary of NRx, today announced they will be featured as a participating in the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York.  The ThinkEquity Conference gathers institutional investors, corporate...

read more
Siyata Mobile to Present at The ThinkEquity Conference

Siyata Mobile to Present at The ThinkEquity Conference

Presentation on October 30 at 4 p.m. ET, and Attend 1x1 Meetings Vancouver, BC, October 23, 2024 - PRISM MediaWire - Siyata Mobile Inc. (Nasdaq: SYTA/SYTAW) (“Siyata” or the “Company”), a global vendor of Push-to-Talk over Cellular (“PoC”) devices and cellular signal booster systems, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York.  The ThinkEquity Conference gathers institutional investors, corporate...

read more
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor

Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor

Discoverer of Klotho gene further strengths KLTO Scientific Advisory Board New York, NY, October 23, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, is proud to announce the appointment of Dr. Makoto Kuro-o to its Scientific Advisory Board. Dr. Kuro-o, a distinguished Japanese physician-scientist, is widely recognized as the pioneer behind the discovery of the...

read more
SPZI: JP3E and China Petroleum Technology and Development Corporation, China’s Largest International Trading Company, Announce Partnership

SPZI: JP3E and China Petroleum Technology and Development Corporation, China’s Largest International Trading Company, Announce Partnership

Jointly Initiating First Coal Shipment Utilizing Bloxcross’ Proprietary Trade Finance Platform NEW YORK, October 22, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), through its wholly-owned subsidiary JP Energy Global PTE, LTD, announces a major strategic partnership with China Petroleum Technology and Development Corporation (CPTDC), China's largest international trading company. This partnership marks a significant milestone with the first coal shipment initiated under the...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850